Please login to the form below

Not currently logged in
Email:
Password:

Edurant

This page shows the latest Edurant news and features for those working in and with pharma, biotech and healthcare.

GSK’s says depot HIV injection works over three years

GSK’s says depot HIV injection works over three years

The combination of ViiV’s integrase inhibitor cabotegravir with non-nucleoside reverse transcriptase inhibitor (NNRTI) rilpivirine – a drug already sold by Janssen as Edurant – is just one of the two-drug

Latest news

More from news
Approximately 2 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

2019: CRISPR and therapeutic gene editing comes of age
Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...
The 10-year Web Challenge
Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....

Infographics